Lenz Therapeutics Inc (LENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 1,588 | 12,500 | 5,000 | 0 | 0 |
| Gross Profit | 1,170 | 12,500 | 5,000 | N/A | N/A |
| Operating Expenses | 40,051 | 31,387 | 21,857 | 16,931 | 15,225 |
| Operating Income | -38,463 | -18,887 | -16,857 | -16,931 | -15,225 |
| Other Income | 2,569 | 2,187 | 2,445 | 2,312 | 2,574 |
| Pre-tax Income | -35,894 | -16,700 | -14,412 | -14,619 | -12,651 |
| Income Tax | 2 | N/A | 500 | N/A | N/A |
| Net Income Continuous | -35,896 | -16,700 | -14,912 | -14,619 | -12,652 |
| Net Income | $-35,896 | $-16,700 | $-14,912 | $-14,619 | $-12,652 |
| EPS Basic Total Ops | -1.20 | -0.59 | -0.53 | -0.53 | 1.97 |
| EPS Basic Continuous Ops | -1.20 | -0.59 | -0.53 | -0.53 | 1.97 |
| EPS Diluted Total Ops | -1.20 | -0.59 | -0.53 | -0.53 | 1.97 |
| EPS Diluted Continuous Ops | -1.20 | -0.59 | -0.53 | -0.53 | 1.97 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.59 | -0.53 | -0.53 | -0.46 |
| EBITDA(a) | $-38,356 | $-16,740 | $-17,726 | $-18,029 | $-15,200 |